# SHF

## Overview
The SHF gene encodes the Src homology 2 domain containing F protein, which is a critical component in cellular signal transduction pathways. This protein, characterized by its SH2 domain, is involved in various cellular processes, including growth, differentiation, and survival, by interacting with phosphorylated tyrosine residues on other proteins. Functionally, the SHF protein is active in both the cytoplasm and nucleus, where it influences cell signaling and development. It is particularly noted for its role in regulating apoptosis in response to platelet-derived growth factor (PDGF) and its interaction with anaplastic lymphoma kinase, which it negatively regulates in neuroblastoma (YamaguchiKabata2018Integrated). The SHF gene has also been implicated in the pathogenesis of Alzheimer's disease, where it may play a protective role by preventing amyloid-beta accumulation through the regulation of phospho-transduction signals (YamaguchiKabata2018Integrated). Additionally, SHF is crucial for cardiac development, with mutations or altered expression linked to congenital heart defects (Miyamoto2021Understanding; Rochais2009Signaling).

## Structure


## Function
The SHF gene encodes a protein containing an SH2 domain, which is involved in signal transduction pathways. This protein plays a role in cellular processes such as growth, differentiation, and survival by interacting with phosphorylated tyrosine residues on other proteins. It is active in the cytoplasm and nucleus, influencing cell signaling and development. The SHF protein is suspected to regulate apoptosis in response to platelet-derived growth factor (PDGF) and interacts with anaplastic lymphoma kinase, negatively regulating its downstream signals in neuroblastoma (YamaguchiKabata2018Integrated). 

In the context of Alzheimer's disease, the SHF gene has been identified as potentially playing a role in preventing the accumulation of amyloid-beta (Aβ) through its ability to regulate phospho-transduction signals. Lower expression levels of SHF in Alzheimer's patients might be associated with increased Aβ accumulation, suggesting a possible protective role against the disease (YamaguchiKabata2018Integrated). However, the specific function of SHF in healthy human cells remains less clear, as most studies focus on its implications in disease contexts rather than its normal physiological roles (YamaguchiKabata2018Integrated).

## Clinical Significance
Mutations and altered expression of the SHF gene have been implicated in several diseases, notably congenital heart defects (CHDs) and Alzheimer's disease (AD). In the context of heart development, SHF is crucial for the proliferation and differentiation of cardiac progenitor cells. Disruptions in SHF expression can lead to various CHDs, including ventricular septal defects, persistent truncus arteriosus, and tetralogy of Fallot (Miyamoto2021Understanding; Rochais2009Signaling). The SHF gene is also associated with hypoplastic right heart syndrome (HRHS), where genetic variants in SHF-related pathways contribute to the underdevelopment of the right ventricle (Wang2019Minor).

In Alzheimer's disease, SHF has been identified as a novel gene associated with amyloid-β (Aβ) accumulation. Studies have shown that lower expression levels of SHF in the hippocampus correlate with increased Aβ accumulation, suggesting a potential protective role against AD pathogenesis (YamaguchiKabata2018Integrated). The gene's involvement in regulating apoptosis and phospho-transduction signals may underlie its role in preventing Aβ accumulation, although further research is needed to clarify these mechanisms (YamaguchiKabata2018Integrated).


## References


[1. (YamaguchiKabata2018Integrated) Yumi Yamaguchi-Kabata, Takashi Morihara, Tomoyuki Ohara, Toshiharu Ninomiya, Atsushi Takahashi, Hiroyasu Akatsu, Yoshio Hashizume, Noriyuki Hayashi, Daichi Shigemizu, Keith A. Boroevich, Manabu Ikeda, Michiaki Kubo, Masatoshi Takeda, and Tatsuhiko Tsunoda. Integrated analysis of human genetic association study and mouse transcriptome suggests lbh and shf genes as novel susceptible genes for amyloid-β accumulation in alzheimer’s disease. Human Genetics, 137(6–7):521–533, July 2018. URL: http://dx.doi.org/10.1007/s00439-018-1906-z, doi:10.1007/s00439-018-1906-z. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-018-1906-z)

[2. (Miyamoto2021Understanding) Matthew Miyamoto, Harshi Gangrade, and Emmanouil Tampakakis. Understanding heart field progenitor cells for modeling congenital heart diseases. Current Cardiology Reports, March 2021. URL: http://dx.doi.org/10.1007/s11886-021-01468-5, doi:10.1007/s11886-021-01468-5. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11886-021-01468-5)

[3. (Wang2019Minor) Enshi Wang, Yu Nie, Xuesong Fan, Zhe Zheng, Haiyong Gu, Hao Zhang, and Shengshou Hu. Minor alleles of genetic variants in second heart field increase the risk of hypoplastic right heart syndrome. Journal of Genetics, May 2019. URL: http://dx.doi.org/10.1007/s12041-019-1092-3, doi:10.1007/s12041-019-1092-3. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12041-019-1092-3)

[4. (Rochais2009Signaling) Francesca Rochais, Karim Mesbah, and Robert G. Kelly. Signaling pathways controlling second heart field development. Circulation Research, 104(8):933–942, April 2009. URL: http://dx.doi.org/10.1161/circresaha.109.194464, doi:10.1161/circresaha.109.194464. This article has 222 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/circresaha.109.194464)